News

News

VitaFlow Liberty™ and Alwide® Plus by CardioFlow Medtech Obtain Marketing Approval in Thailand -

CardioFlow Medtech has recently obtained registration approval in Thai...

ArgusClarity™ OCT System by MicroPort Argus™ Registered for Marketing in Singapore -

MicroPort Argus™ has recently received registration approval in Singap...

First Implantation of Endovastec™'s Castor™ Branched Aortic Stent-Graft System Completed in Netherlands -

The first implantation of the Castor® as been successfully completed i...

MicroPort EP Obtains FDA Approval for EasyFinder™ Fixed Curve Diagnostic Catheter -

MicroPort EP obtained approval in the U.S.....

MicroPort® Joins Singapore LIVE 2023 -

MicroPort® recently participated in the Singapore LIVE 2023 conference...

HorizonMedical™’s Daylily® Embryo Transfer Catheter Obtains FDA 510(k) Approval -

The Daylily® Embryo Transfer Catheter successfully received FDA 510(k)...

Firehawk Liberty™ Rapamycin Target Eluting Coronary Stent System Approved for Marketing in Russia -

MicroPort® has recently received registration approval from the Federa...

Endovastec™ Minos® Abdominal Aortic Stent-Graft and Delivery System Receives Approval for Marketing in South Korea -

Endovastec™ has received registration approval from MFDS for its indep...

MicroPort® Coronary Foxtrot™ NC Balloon Catheter Approved for Sale in Indonesia -

MicroPort® has been granted a registration certificate by the Ministry...

MicroPort® Coronary Balloon Catheters Receive Marketing Approval in Peru -

MicroPort® has recently received marketing registration approval in Pe...

Endovastec™ Completes First Pre-market Clinical Implantation of TIPS Stent Graft System -

Recently, the first pre-market clinical implantation of the TIPS Stent...

MicroPort® MedBot® Performs World's First Robotic Positioned Cryoablation of Prostate Cancer -

The world's first prostate cancer focal treatment using a prostate pos...

MicroPort® MedBot® SkyWalker™ Orthopedic Surgical Robot Obtains CE Marking in EU -

MicroPort® OrthoBot has recently obtained CE marking for SkyWalker™ Or...

6 Endovastec™ Products Approved for Marketing in Belarus -

Recently, 6 products independently developed by Endovastec™ have been ...

TARGET IV-NA Clinical Trial for the Firehawk™ Stent Completes the Last Enrollment -

MicroPort announced that the last patient enrollment for the TARGET IV...

MicroPort® Announces Important Follow-up Results at ESC Congress 2022 -

MicroPort® recently participated in the European Society of Cardiology...